The FDA previously approved FoundationOne CDx, which uses a tumor tissue sample, and FoundationOne Liquid CDx, which uses a ...

A new blood test could detect lung cancer recurrence months before it appears on scans, potentially enabling earlier ...

Abbott’s next-gen Oncodetect molecular residual disease (MRD) test detects traces of circulating tumor DNA in a patient’s ...

Learn what it takes health systems scale molecular residual disease testing for consistent cancer recurrence monitoring and care coordination.

Recent study links blood proteins to aggressive prostate cancer, identifying potential biomarkers for early risk prediction ...

"Colorectal cancer is more common in men" or "Female hormones protect against colorectal cancer." Have you ever heard ...

Mathematicians and clinicians will use AI for healthcare to detect diseases earlier in the human body by revealing new patterns in the full (or complete) blood count test ...

Hong Kong researchers are testing a next-generation PCR system that can analyse blood samples and deliver cancer test results within three to four hours.

Singapore blood test CIRRHOClear could help detect liver cirrhosis risk early and prevent liver failure and liver cancer.

Common blood tests may overlook reduced kidney function in people receiving cancer care, according to research presented at ...

When treatment is urgent, are there clues to foresee the outcome?When you are told of a relapse and must start the next treatment as soon as possible, the first thing many people want to know is, ...